Cargando…
HLA‐DR3 mediated CD4 T cell response against GAD65 in type 1 diabetes patients
AIM: We planned this study to identify diabetogenic glutamic acid decarboxylase (GAD65) peptides possibly responsible for human leucocyte antigen (HLA)‐DR3/DQ2‐mediated activation of GAD65‐specific CD4 T cells in type 1 diabetes (T1D). METHODS: Top 30 GAD65 peptides, found to strongly bind in silico...
Autores principales: | Chuzho, Neihenuo, Mishra, Neetu, Tandon, Nikhil, Kanga, Uma, Mishra, Gunja, Sharma, Akanksha, Mehra, Narinder K., Kumar, Neeraj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Publishing Asia Pty Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345980/ https://www.ncbi.nlm.nih.gov/pubmed/37309552 http://dx.doi.org/10.1111/1753-0407.13406 |
Ejemplares similares
-
Differential HLA Association of GAD65 and IA2 Autoantibodies in North Indian Type 1 Diabetes Patients
por: Chuzho, Neihenuo, et al.
Publicado: (2021) -
Elevated Serum GAD65 and GAD65-GADA Immune Complexes in Stiff Person Syndrome
por: Gu Urban, Gucci Jijuan, et al.
Publicado: (2015) -
Decline in Titers of Anti-Idiotypic Antibodies Specific to Autoantibodies to GAD65 (GAD65Ab) Precedes Development of GAD65Ab and Type 1 Diabetes
por: Larsson, Helena Elding, et al.
Publicado: (2013) -
An Analysis of the Cross-Reactivity of Autoantibodies to GAD65 and GAD67 in Diabetes
por: Jayakrishnan, Bindu, et al.
Publicado: (2011) -
Meningoencephalitis associated with GAD65 autoimmunity
por: Kuang, Zuying, et al.
Publicado: (2023)